Karyopharm Therapeutics, Inc. (KPTI)
7.14
+0.14
(+2.00%)
USD |
NASDAQ |
Dec 12, 10:54
Karyopharm Therapeutics Free Cash Flow: -89.30M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| TG Therapeutics, Inc. | -70.24M |
| Actinium Pharmaceuticals, Inc. | -25.04M |
| Axsome Therapeutics, Inc. | -101.39M |
| Krystal Biotech, Inc. | 165.59M |
| Akebia Therapeutics, Inc. | 32.17M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.86M |
| Cash from Investing (Quarterly) | 4.805M |
| Free Cash Flow Per Share (Quarterly) | -0.676 |
| Free Cash Flow to Equity (Quarterly) | -11.66M |
| Free Cash Flow to Firm (Quarterly) | 5.159M |
| Free Cash Flow Yield | -146.5% |